While examining biomedical signals, signal classification as well as measurements, quantifications and their assessment is very important for studying different diseases and disorders. Through this paper, we have focused on different signals and biomedical devices, whose purpose is to give high quality information about diseases and disorders in prenatal age. The main focus was on ultrasound techniques and the relationship between 2D, 3D and 4D ultrasound, on Doppler ultrasound, cardiotocography, KANET test, and in general, comparison of standardized and automated techniques. Purpose of this paper is to compare some of the available techniques used to assess the fetus in the womb, how they advance through time and whether they are being automated.

Pulmonary emphysema is a complicated disease caused by irreversible damage to the wall of the pulmonary alveoli and causes 5% of the total mortality worldwide. This paper presents the development of an artificial neural network (ANN) for the diagnosis of pulmonary emphysema. Following biomarkers were used for the development of the ANN: AAT (alphal-antitrypsin), FEV1 (forced expiratory volume in 1 second), FVC (forced vital capacity) and FEV1/FVC (ratio forced expiratory volume in 1 second / forced vital capacity). The dataset consisted of 300 patients: 210 healthy subjects and 90 subject with disease. The neural network has 4 input parameters and 1 output parameter. For the final architecture, a neural network with 13 neurons in hidden layer was chosen based on the training results. The developed ANN has shown good performance and has a potential for use in this field.

As a consequence of the progress of the modern mobile medicine, wearable technologies, especially ECG wearables tend to become indispensable part of peoples' lives. As applications and devices for tracking cardiac electrical activity are rapidly entering the market, it is important to compare individual ECG wearable devices. This review takes a systematic approach on the analysis of wearable ECG devices. It provides a detailed introduction on the updated methods, to create a comparison between individual features of devices, and to evaluate techniques for fall risk assessment, diagnosis, and prevention. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) instructions were used as a report standard. In an effort to collect the appropriate data, various databases were queried together with specific subject-oriented keywords. This was combined with different inclusion and exclusion criteria to find the relevant data. To further improve the data gathering and reduce bias, a Zotero tool was used. The results of this paper show the comparison of the different devices and their features. All findings can be observed in the table and in words. As information for the QardioCore are scarce, all six authors consolidated on the VitalCore being the most accurate ECG wearable device, as its sensitivity and specificity are the highest. Recent advances in wearable ECG devices allow for more trouble free out of clinic fall risk assessment, detection and prevention. As people tend to prefer the comfort of their home over doctors, such progress will assure the everyday emerging of new wearables.

Machine learning algorithms have been drawing attention in lung disease research. However, due to their algorithmic learning complexity and the variability of their architecture, there is an ongoing need to analyze their performance. This study reviews the input parameters and the performance of machine learning applied to diagnosis of chronic obstructive pulmonary disease (COPD). One research focus of this study was on clearly identifying problems and issues related to the implementation of machine learning in clinical studies. Following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) protocol, 179, 1032, and 36,500 titles were identified from the PubMed, Scopus, and Google Scholar databases respectively. Studies that used machine learning to detect COPD and provided performance measures were included in our analysis. In the final analysis, 24 studies were included. The analysis of machine learning methods to detect COPD reveals the limited usage of the methods and the lack of standards that hinder the implementation of machine learning in clinical applications. The performance of machine learning for diagnosis of COPD was considered satisfactory for several studies; however, given the limitations indicated in our study, further studies are warranted to extend the potential use of machine learning to clinical settings.

Diagnostic medical imaging and the interpretation of the imaging results pose a great challenge for the medical profession as the final conclusions are highly susceptible to human error and subjectivity. The necessity for standardization of interpretation of medical images is very necessary to bypass these problems. The only way of achieving this is using a methodology which excludes the human eye and employs artificial intelligence. However, another challenge is selecting the most suitable AI algorithm fit for the challenging task of imaging results interpretation. This study was conducted following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines published in 2020. Research was done using PubMed, ScienceDirect and Google Scholar databases where the key inclusion criteria were language, journal credibility, open access to full-text publications and the most recent papers. In order to focus on only the most recent research, only the papers published in the last 5 years were evaluated. The search through PubMed, ScienceDirect and Google Scholar has yielded 81, 205, and 520 papers respectively. Out of this number of papers, 26 of them have met all of the inclusion criteria and were included in the research. The observed accuracies of the models and the overall rising interest in the topic denote that this field is rapidly growing and has a great potential to be applied in daily medical practice in the future.

The activities related to medical device market can be divided into pre-market and post-market surveillance. Pre-market processes have been defined by Medical Device Directives since 1992. These directives define all aspects of medical device design, production, testing, approval and certification. Appropriate standards have been adopted to support these activities. The CE mark issued by European Notified Bodies confirms that the medical device complies with safety and performance standards related to its class and that is therefore safe for intended usage. Post-market surveillance is not as well defined, so the new Medical Device Regulation addresses the identified gap and emphasizes the importance of standardizing and harmonizing the system for surveillance of medical devices already in use. The MDRs require stakeholders to monitor the quality, performance and safety of a device throughout its life cycle and to take corrective or preventive action when necessary. In this paper, we discuss the possibility of using artificial intelligence on Big Data structures resulting from the comprehensive methodology of post-market surveillance.